デフォルト表紙
市場調査レポート
商品コード
1320003

非オピオイド鎮痛パッチ市場:パッチタイプ、適応症、流通別-2023~2030年の世界予測

Non-opioid Pain Patches Market by Patch Type, Indication, Distribution - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 190 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
非オピオイド鎮痛パッチ市場:パッチタイプ、適応症、流通別-2023~2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

非オピオイド鎮痛パッチの世界市場は、2023年にCAGR 12.86%で7億129万米ドルと予測され、2030年には16億3,777万米ドルに達するという驚異的な成長を遂げると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の非オピオイド鎮痛パッチ市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.非オピオイド鎮痛パッチの世界市場規模および予測は?

2.予測期間中、世界の非オピオイド鎮痛パッチ市場を形成するCOVID-19の阻害要因と影響は?

3.非オピオイド鎮痛パッチの世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は?

4.非オピオイド鎮痛パッチの世界市場における競争戦略は?

5.非オピオイド鎮痛パッチの世界市場における技術動向と規制の枠組みは?

6.非オピオイド鎮痛パッチの世界市場における主要ベンダーの市場シェアは?

7.非オピオイド鎮痛パッチの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性および急性の疼痛関連疾患の増加
      • 非オピオイドパッチに対する医療専門家の傾向の高まり
      • 従来の薬に比べて非オピオイド鎮痛パッチに関連する利点
    • 抑制要因
      • 非オピオイド鎮痛パッチに関連する認識が限定的
    • 機会
      • 非依存性疼痛治療法に対する政府の好意的な取り組み
      • 疼痛管理治療における研究開発の増加
    • 課題
      • 重大な副作用と代替治療の利用可能性
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 非オピオイド鎮痛パッチ市場:パッチタイプ別

  • イントロダクション
  • カプサイシンパッチ
  • ジクロフェナクパッチ
  • ケトプロフェンパッチ
  • リドカインパッチ
  • サリチル酸メチルパッチ

第7章 非オピオイド鎮痛パッチ市場:適応症別

  • イントロダクション
  • 関節炎
  • 背中の痛み
  • 線維筋痛症
  • 片頭痛と頭痛
  • 筋肉の緊張と捻挫
  • 帯状疱疹後神経痛

第8章 非オピオイド鎮痛パッチ市場:流通別

  • イントロダクション
  • ドラッグストア
  • 病院
  • オンライン薬局

第9章 南北アメリカの非オピオイド鎮痛パッチ市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の非オピオイド鎮痛パッチ市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの非オピオイド鎮痛パッチ市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. NON-OPIOID PAIN PATCHES MARKET RESEARCH PROCESS
  • FIGURE 2. NON-OPIOID PAIN PATCHES MARKET SIZE, 2022 VS 2030
  • FIGURE 3. NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2022 VS 2030 (%)
  • FIGURE 5. NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
  • FIGURE 6. NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
  • FIGURE 7. NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. NON-OPIOID PAIN PATCHES MARKET DYNAMICS
  • FIGURE 9. NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. NON-OPIOID PAIN PATCHES MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. NON-OPIOID PAIN PATCHES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. NON-OPIOID PAIN PATCHES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. NON-OPIOID PAIN PATCHES MARKET SIZE, BY CAPSAICIN PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. NON-OPIOID PAIN PATCHES MARKET SIZE, BY DICLOFENAC PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NON-OPIOID PAIN PATCHES MARKET SIZE, BY KETOPROFEN PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NON-OPIOID PAIN PATCHES MARKET SIZE, BY LIDOCAINE PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. NON-OPIOID PAIN PATCHES MARKET SIZE, BY METHYL SALICYLATE PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 11. NON-OPIOID PAIN PATCHES MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. NON-OPIOID PAIN PATCHES MARKET SIZE, BY BACK PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NON-OPIOID PAIN PATCHES MARKET SIZE, BY FIBROMYALGIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NON-OPIOID PAIN PATCHES MARKET SIZE, BY MIGRAINES & HEADACHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. NON-OPIOID PAIN PATCHES MARKET SIZE, BY MUSCLE STRAIN & SPRAINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. NON-OPIOID PAIN PATCHES MARKET SIZE, BY POST-HERPETIC NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 18. NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. NON-OPIOID PAIN PATCHES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 148. NON-OPIOID PAIN PATCHES MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 149. NON-OPIOID PAIN PATCHES MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 150. NON-OPIOID PAIN PATCHES MARKET LICENSE & PRICING
目次
Product Code: MRR-AD36CD897D8F

The Global Non-opioid Pain Patches Market is forecasted to grow significantly, with a projected USD 701.29 million in 2023 at a CAGR of 12.86% and expected to reach a staggering USD 1,637.77 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Non-opioid Pain Patches Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Non-opioid Pain Patches Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Patch Type, market is studied across Capsaicin Patches, Diclofenac Patches, Ketoprofen Patches, Lidocaine Patches, and Methyl Salicylate Patches. The Diclofenac Patches is projected to witness significant market share during forecast period.

Based on Indication, market is studied across Arthritis, Back Pain, Fibromyalgia, Migraines & Headaches, Muscle Strain & Sprains, and Post-Herpetic Neuralgia. The Back Pain is projected to witness significant market share during forecast period.

Based on Distribution, market is studied across Drug Stores, Hospitals, and Online Pharmacies. The Online Pharmacies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Non-opioid Pain Patches Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Non-opioid Pain Patches Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Non-opioid Pain Patches Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Non-opioid Pain Patches Market?

4. What is the competitive strategic window for opportunities in the Global Non-opioid Pain Patches Market?

5. What are the technology trends and regulatory frameworks in the Global Non-opioid Pain Patches Market?

6. What is the market share of the leading vendors in the Global Non-opioid Pain Patches Market?

7. What modes and strategic moves are considered suitable for entering the Global Non-opioid Pain Patches Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Non-opioid Pain Patches Market, by Patch Type, 2022 vs 2030
  • 4.3. Non-opioid Pain Patches Market, by Indication, 2022 vs 2030
  • 4.4. Non-opioid Pain Patches Market, by Distribution, 2022 vs 2030
  • 4.5. Non-opioid Pain Patches Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Chronic and Acute Pain-Related Disorders
      • 5.1.1.2. Growing Inclination of Healthcare Professionals towards Non-Opioid Patches
      • 5.1.1.3. Benefits Associated with Non-opioid Pain Patches over Conventional Medications
    • 5.1.2. Restraints
      • 5.1.2.1. Limited Awareness Associated with Non-opioid Pain Patches
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable Government Initiatives towards Non-Addictive Pain Therapeutic Solutions
      • 5.1.3.2. Rising R&D in Pain Management Treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Significant Side Effect Coupled with Availability of Alternative Treatments
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Non-opioid Pain Patches Market, by Patch Type

  • 6.1. Introduction
  • 6.2. Capsaicin Patches
  • 6.3. Diclofenac Patches
  • 6.4. Ketoprofen Patches
  • 6.5. Lidocaine Patches
  • 6.6. Methyl Salicylate Patches

7. Non-opioid Pain Patches Market, by Indication

  • 7.1. Introduction
  • 7.2. Arthritis
  • 7.3. Back Pain
  • 7.4. Fibromyalgia
  • 7.5. Migraines & Headaches
  • 7.6. Muscle Strain & Sprains
  • 7.7. Post-Herpetic Neuralgia

8. Non-opioid Pain Patches Market, by Distribution

  • 8.1. Introduction
  • 8.2. Drug Stores
  • 8.3. Hospitals
  • 8.4. Online Pharmacies

9. Americas Non-opioid Pain Patches Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Non-opioid Pain Patches Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Non-opioid Pain Patches Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing